FEROX STRATEGIES

Lobbying for ALEXION PHARMACEUTICALS, INC. · Rare Disease Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Issues related to rare disease pharmaceuticals, ORPHAN Cures, and Pediatric Priority Review Voucher

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.